Common bacteria activating natural killer T cells may cause autoimmune liver diseaseMay 15, 2008Researchers close in on possible cause of primary biliary cirrhosis CINCINNATI - A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC). Reporting their findings in the May 15 Cell Host & Microbe, the multi-institutional research team said injecting laboratory mice with the bacterium - Novosphingobium aromaticivorans - prompted activation of Natural Killer T (NKT) cells, which were critical to initiating autoimmune processes that led to liver disease. Besides pointing to a possible cause for PBC, the study also provides scientists a model that will enhance future research of this and other autoimmune disorders, said Jochen Mattner, M.D., a physician and researcher in the Division of Immunobiology at Cincinnati Children's Hospital Medical Center and lead author of the study.
Undetected infections are increasingly pointed to in ongoing research as possible triggers of autoimmune disease, in which the immune system - designed to fight infection or disease - instead attacks the body's own tissues. Precisely how microbes (such as bacteria or viruses) engage cellular and molecular processes to cause autoimmunity remains unknown, as does the cause of PBC. PBC results in inflammatory lesions within the portal fields and subsequent destruction of small bile ducts of the liver. "Our study of autoimmunity in PBC showed that NKT cells react to glycosphingolipid antigens, which promote cell attraction and immune response and are located in the bacterial cell wall of Novosphingobium aromaticivorans. This microbial activation of NKT cells was as an essential trigger of autoimmune processes that led to disease-like symptoms in mice," said Dr. Mattner, who started the study at the University of Chicago. "We aren't suggesting this bacterium is the only possible cause of PBC, but it does present a model having significant implications for understanding immunological tolerance and autoimmunity." Previous research has shown that patients with PBC have a buildup of certain autoantibodies that attack an enzyme complex found in mitochondria, which are the energy source of most cells. Those same autoantibodies also cross react with a corresponding enzyme of Novosphingobium aromaticivorans, an alpha-proteobacterium with an evolutionary relationship to mitochondria. This relationship has led researchers in previous studies to suggest that Novosphingobium aromaticivorans may have a role in PBC, and it was a factor in Dr. Mattner's research team using the bacterium in this study. When the researchers injected mice with the bacterium, it prompted the production of autoantibodies against the mitochondrial enzyme complex in similar fashion to that observed in patients. This triggered chronic autoimmunity that damaged small bile ducts in the animal's livers. The autoimmune process was mediated by T cells (a white blood cell important to immune response), but early disease onset required the participation of Natural Killer T cells after they selectively recognized glycosphingolipid antigens on the cell wall surface of Novosphingobium aromaticivorans. NKT cells are a unique group of T cells that share properties of both T cells and Natural Killer cells, which are naturally toxic to other cells and typically target tumor cells or cells infected with viruses. The natural presence of NKT cells in the liver, combined with an accumulation of Novosphingobium aromaticivorans, likely explains why the liver is damaged during this autoimmune process, Dr. Mattner said. After the research team established chronic autoimmune liver disease in mice, they performed studies to see if they could transfer the disease with spleen T cells from infected livers into a second group of mice. T cells from mice having CD1d (a glycoprotein important to activating NKT cells) caused autoimmune liver disease in recipient mice, although cells from CD1d deficient mice (which lack NKT cells) did not. Dr. Mattner said this result illustrates the importance of early microbial activation of NKT cells in the early stages of autonomous, organ-specific autoimmunity. Although NKT cells were not critical to transferring already established disease, they are extremely important in the early onset stages by helping break down the body's tolerance for infection, the researchers said. The researchers were also able to prevent or slow autoimmune liver disease in some mice, either by early intervention with antibiotics, or by deleting the gene that encodes the CD1d glycoprotein and its activation of NKT cell attraction to Novosphingobium aromaticivorans. PBC is relatively rare, occurring in about five of every 100,000 people. Disease prevalence and rate of occurrence vary in different regions of the world. About 90 percent of patients are women, and the disease is more common in patients between 40 and 60 years old. Patients typically experience itching, jaundice and can have increased blood pressure that leads to fluid retention in the abdomen, as well as other symptoms. Because there is no cure for PBC, treatment focuses mostly on trying to alleviate symptoms with medication, or in some cases liver transplant in the event of organ failure. Cincinnati Children's Hospital Medical Center Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Bird Species Cell Death Emissions Antarctic Behavior Television Nicotine Dependence Solar Wind Iron Immunization Flooding Fruit Flies Bacteria Gene Therapy Ice Core Carbon Nanotubes Superconductor Spinal Cord Fish Oil Defibrillator Vision Loss Toxoplasmosis Back Pain Water Purification Facial Expressions
See More: Science News Tags | |||||||||||||||||||||
|
Related Autoimmune Current Events and Autoimmune News Articles New clue into how brain stem cells develop into cells which repair damaged tissue The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco (UCSF) and University of Cambridge and was published today (01 July) in the journal Genes and Development. UT researcher: Interferon alpha can delay full onset of type I diabetes A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes. Scripps research scientists find key culprits in lupus The more than 1.5 million Americans with systemic lupus erythematosus (or lupus) suffer from a variety of symptoms that flare and subside, often including painful or swollen joints, extreme fatigue, skin rashes, fever, and kidney problems. New trigger for chronic inflammation in rheumatoid arthritis discovered A signal molecule made by the human body that triggers the immune system into action may be important in rheumatoid arthritis. CSHL scientists harness logic of 'Sudoku' math puzzle to vastly enhance genome-sequencing capability A math-based game that has taken the world by storm with its ability to delight and puzzle may now be poised to revolutionize the fast-changing world of genome sequencing and the field of medical genetics. Adding antiviral agents to steroids to treat facial paralysis is not linked to improved recovery Adding an antiviral agent to corticosteroids for treatment of Bell's palsy (a condition characterized by partial facial paralysis) is not associated with improved recovery of facial movement function. Aussie and Kiwi researchers make double MS genetic discovery Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease. Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus (SLE). Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients 92.8% of patients with systemic lupus erythematosus (SLE) suffer anxiety and depression which significantly affects both their physical and emotional quality of life (QoL). Mouse experiments shed light on age effects in arthritis Older mice are more susceptible to proteoglycan-induced arthritis (PGIA). Researchers writing in BioMed Central's open access journal Immunity & Ageing have shown, for the first time, that young mice are completely resistant, but become fully susceptible to the disease with age. More Autoimmune Current Events and Autoimmune News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||